These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 6222070

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. HTLV-I antibody status in hemophilia patients treated with factor concentrates prepared from U.S. plasma sources and in hemophilia patients with AIDS.
    Chorba TL, Jason JM, Ramsey RB, Lechner K, Pabinger-Fasching I, Kalyanaraman VS, McDougal JS, Cabradilla CD, Tregillus LC, Lawrence DN.
    Thromb Haemost; 1985 Apr 22; 53(2):180-2. PubMed ID: 2992112
    [Abstract] [Full Text] [Related]

  • 24. Impaired immune function in hemophilia patients treated exclusively with cryoprecipitate: relation to duration of treatment.
    Pollack S, Atias D, Yoffe G, Katz R, Shechter Y, Tatarsky I.
    Am J Hematol; 1985 Sep 22; 20(1):1-6. PubMed ID: 3927714
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Impaired cell-mediated immunity in hemophilia. II. Persistence of subclinical immunodeficiency and enhancement of natural killer activity by lymphokines.
    Lederman MM, Ratnoff OD, Schacter B, Shoger T.
    J Lab Clin Med; 1985 Aug 22; 106(2):197-204. PubMed ID: 2410523
    [Abstract] [Full Text] [Related]

  • 29. Development and early natural history of HTLV-III antibodies in persons with hemophilia.
    Eyster ME, Goedert JJ, Sarngadharan MG, Weiss SH, Gallo RC, Blattner WA.
    JAMA; 1985 Apr 19; 253(15):2219-23. PubMed ID: 2983132
    [Abstract] [Full Text] [Related]

  • 30. Deficiency of the autologous mixed lymphocyte reaction in patients with classic hemophilia treated with commercial factor VIII concentrate. Correlation with T cell subset distribution, antibodies to lymphadenopathy-associated or human T lymphotropic virus, and analysis of the cellular basis of the deficiency.
    Smolen JS, Bettelheim P, Köller U, McDougal S, Graninger W, Luger TA, Knapp W, Lechner K.
    J Clin Invest; 1985 Jun 19; 75(6):1828-34. PubMed ID: 2989334
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. HTLV-III status and abnormalities in T lymphocyte distribution in children with hemophilia A.
    Shannon BT, Roach J, Cheek-Luten M, Ruymann FB.
    Diagn Immunol; 1986 Jun 19; 4(1):37-42. PubMed ID: 3006971
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Helper and suppressor T-cell function in HIV-infected hemophilia patients.
    Weimer R, Schweighoffer T, Schimpf K, Opelz G.
    Blood; 1989 Jul 19; 74(1):298-302. PubMed ID: 2568859
    [Abstract] [Full Text] [Related]

  • 36. HTLV-III infection in homosexuals and hemophiliacs in Sweden.
    Biberfeld G, Böttiger B, Karlsson A, Sandström E, Morfeldt-Månsson L, Blombäck M, Nilsson IM, Wiechel B, Saxinger C, Gallo R.
    Cancer Res; 1985 Sep 19; 45(9 Suppl):4609s-4611s. PubMed ID: 2990693
    [Abstract] [Full Text] [Related]

  • 37. A functional defect in the early phase of the immune response observed in patients with hemophilia A.
    Mannhalter JW, Zlabinger GJ, Ahmad R, Zielinski CC, Schramm W, Eibl MM.
    Clin Immunol Immunopathol; 1986 Mar 19; 38(3):390-7. PubMed ID: 3002697
    [Abstract] [Full Text] [Related]

  • 38. Isolation of human immunodeficiency virus from hemophiliacs: correlation with clinical symptoms and immunologic abnormalities.
    Andrews CA, Sullivan JL, Brettler DB, Brewster FE, Forsberg AD, Scesney S, Levine PH.
    J Pediatr; 1987 Nov 19; 111(5):672-7. PubMed ID: 2959763
    [Abstract] [Full Text] [Related]

  • 39. [HTLV-III antibodies and immunologic changes in hemophilic children. Prevalence of HTLV-III antibodies in hemophilic children and their relatives living in the same household].
    Zenz W, Muntean W, Teubl I, Beaufort F, Heinz FX.
    Padiatr Padol; 1987 Nov 19; 22(1):33-41. PubMed ID: 3108827
    [Abstract] [Full Text] [Related]

  • 40. Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions.
    Kaplan J, Sarnaik S, Gitlin J, Lusher J.
    Blood; 1984 Jul 19; 64(1):308-10. PubMed ID: 6234037
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.